[HTML][HTML] Present and Future of IgA Nephropathy and Membranous Nephropathy Immune Monitoring: Insights from Molecular Studies
F Zanoni, M Abinti, M Belingheri… - International Journal of …, 2023 - mdpi.com
IgA Nephropathy (IgAN) and Membranous Nephropathy (MN) are primary immune-mediated
glomerular diseases with highly variable prognosis. Current guidelines recommend that …
glomerular diseases with highly variable prognosis. Current guidelines recommend that …
Present and Future of IgA Nephropathy and Membranous Nephropathy Immune Monitoring: Insights from Molecular Studies
F Zanoni, M Abinti, M Belingheri… - International Journal of …, 2023 - search.proquest.com
Abstract IgA Nephropathy (IgAN) and Membranous Nephropathy (MN) are primary immune-
mediated glomerular diseases with highly variable prognosis. Current guidelines …
mediated glomerular diseases with highly variable prognosis. Current guidelines …
[HTML][HTML] Present and Future of IgA Nephropathy and Membranous Nephropathy Immune Monitoring: Insights from Molecular Studies
F Zanoni, M Abinti, M Belingheri… - International Journal of …, 2023 - ncbi.nlm.nih.gov
Abstract IgA Nephropathy (IgAN) and Membranous Nephropathy (MN) are primary immune-
mediated glomerular diseases with highly variable prognosis. Current guidelines …
mediated glomerular diseases with highly variable prognosis. Current guidelines …
Present and Future of IgA Nephropathy and Membranous Nephropathy Immune Monitoring: Insights from Molecular Studies
F Zanoni, M Abinti, M Belingheri… - … journal of molecular …, 2023 - pubmed.ncbi.nlm.nih.gov
IgA Nephropathy (IgAN) and Membranous Nephropathy (MN) are primary immune-mediated
glomerular diseases with highly variable prognosis. Current guidelines recommend that …
glomerular diseases with highly variable prognosis. Current guidelines recommend that …
Present and Future of IgA Nephropathy and Membranous Nephropathy Immune Monitoring: Insights from Molecular Studies.
F Zanoni, M Abinti, M Belingheri… - … Journal of Molecular …, 2023 - search.ebscohost.com
Abstract IgA Nephropathy (IgAN) and Membranous Nephropathy (MN) are primary immune-
mediated glomerular diseases with highly variable prognosis. Current guidelines …
mediated glomerular diseases with highly variable prognosis. Current guidelines …
Present and Future of IgA Nephropathy and Membranous Nephropathy Immune Monitoring: Insights from Molecular Studies
F Zanoni, M Abinti, M Belingheri… - International Journal of …, 2023 - agris.fao.org
IgA Nephropathy (IgAN) and Membranous Nephropathy (MN) are primary immune-mediated
glomerular diseases with highly variable prognosis. Current guidelines recommend that …
glomerular diseases with highly variable prognosis. Current guidelines recommend that …
Present and Future of IgA Nephropathy and Membranous Nephropathy Immune Monitoring: Insights from Molecular Studies.
F Zanoni, M Abinti, M Belingheri… - International Journal of …, 2023 - europepmc.org
IgA Nephropathy (IgAN) and Membranous Nephropathy (MN) are primary immune-mediated
glomerular diseases with highly variable prognosis. Current guidelines recommend that …
glomerular diseases with highly variable prognosis. Current guidelines recommend that …
[引用][C] Present and Future of IgA Nephropathy and Membranous Nephropathy Immune Monitoring: Insights from Molecular Studies
F Zanoni, M Abinti, M Belingheri, G Castellano - Int. J. Mol. Sci, 2023 - europepmc.org
IgA Nephropathy (IgAN) and Membranous Nephropathy (MN) are primary immunemediated
glomerular diseases with highly variable prognosis. Current guidelines recommend that …
glomerular diseases with highly variable prognosis. Current guidelines recommend that …